gvtcx

supplier

Chugai Pharma UK Ltd

W41NN

Chugai Pharma UK Ltd has won 20 UK public sector awards from 6 buyers since 2017. The typical award is worth £261,895,933.

as a supplier

20 recorded awards from 6 buyers , between 10 Aug 2017 and 24 Jun 2025.

awards won
20
exclusive
10%
2 sole-winner awards
median award
£261.9m
largest
£418.8m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Chugai Pharma UK Ltd

How many public sector contracts has Chugai Pharma UK Ltd won?

Chugai Pharma UK Ltd has won 20 UK public sector contracts from 6 public bodies since 2017.

Which public bodies buy from Chugai Pharma UK Ltd?

Chugai Pharma UK Ltd has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and eTenderwales.

How large are Chugai Pharma UK Ltd's contracts?

The median published value of a contract won by Chugai Pharma UK Ltd is £261,895,933. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Chugai Pharma UK Ltd contracts are expiring soon?

2 contracts involving Chugai Pharma UK Ltd have end dates in the next 12 months, the earliest on 31 Aug 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Branded Medicines Tranche Framework for London and South of England shared NHS England £380,950,720 21 Jul 2024
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 shared NHS England £688,010,000 26 Jan 2024
NHS South of England Branded Medicines - Tranche A - September 2023 shared NHS ENGLAND £249,832,000 17 Jul 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A) shared NHS England £232,000,000 10 Aug 2017
Proprietary Drugs shared eTenderwales · 28 Jul 2025
NP39724 Generic and Biosimilar Cancer Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 27 Feb 2025
NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 shared NHS England · 10 Feb 2025
NHS Branded Medicines Tranche Framework for London and South of England shared NHS England · 5 Mar 2024
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 shared NHS England · 24 Oct 2023
Generic and Biosimilar Cancer Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · 21 Apr 2023
NHS North of England Branded Medicines Tranche A & Annual Tranche shared NHS England · 15 Mar 2023
NHS South of England Branded Medicines - Tranche A - September 2023 shared NHS ENGLAND · 7 Dec 2022
Proprietary Drugs shared Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) · 14 Jul 2022
NHS Framework for Midlands and East, Branded Medicines – Tranche A and Annual shared The NHS Commissioning Board (operating under the name of NHS England) · 22 Feb 2022
Lenograstim (Granocyte®) The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · 26 Jan 2022
Netupitant/Palonosetron (Akynzeo®) The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · 17 Nov 2021

every contract won by Chugai Pharma UK Ltd →

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.